Diabetes Medication Use and Blood Lactate Level among Participants with Type 2 Diabetes: The Atherosclerosis Risk in Communities Carotid MRI Study

• Morgana L. Mongraw-Chaffin ,

  * E-mail: mmongraw@jhsph.edu

  Affiliation Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  ⨯
• Kunihiro Matsushita,

  Affiliation Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  ⨯
• Frederick L. Brancati,

  Affiliations Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America, Department of Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America

  ⨯
• Brad C. Astor,

  Affiliations Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America

  ⨯
• Josef Coresh,

  Affiliations Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America, Department of Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America

  ⨯
• Stephen O. Crawford,

  Affiliations Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America, Davita Clinical Research, Inc, Minneapolis, Minnesota, United States of America

  ⨯
• Maria Inês Schmidt,

  Affiliations School of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil, Department of Epidemiology, School of Public Health at Chapel Hill, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Ron C. Hoogeveen,

  Affiliations Section of Atherosclerosis and Vascular Medicine, Department of Medicine, Baylor College of Medicine, Houston, Texas, United States of America, Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart Center, Houston, Texas, United States of America

  ⨯
• Christie M. Ballantyne,

  Affiliations Section of Atherosclerosis and Vascular Medicine, Department of Medicine, Baylor College of Medicine, Houston, Texas, United States of America, Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart Center, Houston, Texas, United States of America

  ⨯
• Jeffery Hunter Young

  Affiliations Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America, Department of Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America

  ⨯